We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
RBC Bearings
RBC
$18B
| $82.3M | 0.1% |
275,194
-8,243
| -3% | -$2.54M |
|
77
Vertex
VERX
$1.91B
| $81.2M | 0.1% |
1,521,537
-44,457
| -3% | -$2.16M |
|
78
Insmed
INSM
$28.8B
| $81.1M | 0.1% |
1,174,791
-35,396
| -3% | -$2.55M |
|
79
Life Time Group Holdings
LTH
$9.57B
| $75.8M | 0.1% |
3,425,925
+375,672
| +12% | +$8.98M |
|
80
Texas Roadhouse
TXRH
$13.6B
| $74.8M | 0.09% |
414,776
-12,366
| -3% | -$2.33M |
|
81
Advanced Energy
AEIS
$13.3B
| $74.8M | 0.09% |
647,060
-19,446
| -3% | -$2.19M |
|
82
Integer Holdings
ITGR
$4.26B
| $74M | 0.09% |
558,715
+20,688
| +4% | +$2.76M |
|
83
Weatherford International
WFRD
$6.32B
| $72.1M | 0.09% |
1,006,593
-50,869
| -5% | -$4.17M |
|
84
MACOM Technology Solutions
MTSI
$23.8B
| $70.6M | 0.09% |
543,823
-102,723
| -16% | -$12.9M |
|
85
Diamondback Energy
FANG
$53.9B
| $70.6M | 0.09% |
431,178
-15,382
| -3% | -$2.71M |
|
86
ATI
ATI
$31.7B
| $69.3M | 0.09% |
1,259,227
-37,928
| -3% | -$2.24M |
|
87
PJT Partners
PJT
$4.34B
| $67.6M | 0.09% |
428,365
-64,444
| -13% | -$9.83M |
|
88
Alkermes
ALKS
$8.21B
| $66.2M | 0.08% |
2,302,905
+419,969
| +22% | +$12.1M |
|
89
Kratos Defense & Security Solutions
KTOS
$11.5B
| $65.7M | 0.08% |
2,489,293
-72,742
| -3% | -$1.86M |
|
90
Knife River
KNF
$3.73B
| $65.4M | 0.08% |
643,388
-16,837
| -3% | -$1.65M |
|
91
Agilysys
AGYS
$3.04B
| $64.3M | 0.08% |
488,159
-14,263
| -3% | -$1.75M |
|
92
Construction Partners
ROAD
$6.75B
| $64.2M | 0.08% |
726,193
-21,219
| -3% | -$1.85M |
|
93
Magnolia Oil & Gas
MGY
$6.05B
| $63.2M | 0.08% |
2,701,392
-81,158
| -3% | -$2.11M |
|
94
Hexcel
HXL
$7.81B
| $62.6M | 0.08% |
998,742
-29,948
| -3% | -$1.85M |
|
95
Sterling Infrastructure
STRL
$16.9B
| $62.4M | 0.08% |
370,185
-10,787
| -3% | -$1.86M |
|
96
KBR
KBR
$4.79B
| $61.4M | 0.08% |
1,060,439
-196,123
| -16% | -$12.5M |
|
|
AZEK
97
DELISTED
The AZEK Co
AZEK
| $60.8M | 0.08% |
1,281,538
+58,751
| +5% | +$2.81M |
|
98
Trip.com Group
TCOM
$29.3B
| $59.3M | 0.07% |
863,246
-230,939
| -21% | -$15.3M |
|
99
Silicon Laboratories
SLAB
$7.23B
| $58.4M | 0.07% |
469,883
+8,992
| +2% | +$1.03M |
|
100
RadNet
RDNT
$5.75B
| $58.3M | 0.07% |
834,746
-24,390
| -3% | -$1.8M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.